China SXT Pharmaceuticals, Inc.

The current price of SXTC is 1.0200 USD — it has increased by 3.03% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange China SXT Pharmaceuticals, Inc. stocks are traded under the ticker SXTC.

SXTC stock is 14.30% volatile and has beta coefficient of 0.85. Check out the list of the most volatile stocks — is China SXT Pharmaceuticals, Inc. there?

Yes, you can track China SXT Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.

SXTC stock has fallen by 29.66% compared to the previous week, the month change is a 38.55% fall, over the last year China SXT Pharmaceuticals, Inc. has showed a 82.43% decrease.

SXTC net income for the last quarter is ‪−9.70 M‬ USD, while the quarter before that showed ‪−4.44 M‬ USD of net income which accounts for −118.37% change. Track more China SXT Pharmaceuticals, Inc. financial stats to get the full picture.

No, SXTC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, SXTC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade China SXT Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.

SXTC reached its all-time high on Jan 10, 2019 with the price of 46700.0000 USD, and its all-time low was 1.3900 USD and was reached on Apr 11, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 20, 2024, the company has 78.00 employees. See our rating of the largest employees — is China SXT Pharmaceuticals, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So China SXT Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating China SXT Pharmaceuticals, Inc. stock shows the sell signal. See more of China SXT Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. China SXT Pharmaceuticals, Inc. EBITDA is ‪−13.56 M‬ USD, and current EBITDA margin is −271.72%. See more stats in China SXT Pharmaceuticals, Inc. financial statements.